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DW MRIAbstract Objective: To clarify role of Diffusion Weighted Magnetic Resonance Imaging (DW
MRI) in the detection of hepatic focal lesions and its ability to differentiate benign from malignant
hepatic focal lesions.
Patients and methods: This study included 40 patients who were referred to our institution from the
different medical and surgical departments as well as oncology unit. Patients with chronic renal
impairment or previous allergy to the contrast media were excluded from the study. All patients
were subjected to careful history taking, general and abdominal examination, laboratory examina-
tions, and liver MRI.
Results: The lowest ADCs were found in metastases, CCA and HCCs and the highest values were
found in hemangiomas. The difference between the mean ADC values of benign and malignant
lesions was signiﬁcant. No signiﬁcant differences in ADC values among the different benign lesions
or among the different malignant lesions at both sequences.
Conclusion: In conclusion, DW MRI alone performs equally well as Gd-MRI in detection and dif-
ferentiation of different hepatic focal lesions. In cases where gadolinium injection is not allowed,
dynamic contrast-enhanced imaging can be replaced by a protocol based on unenhanced T1 and
T2 weighted imaging combined with DWI. Adding DWI to Gd-MRI is more accurate.
 2015 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V. All
rights reserved.1. Introduction
The liver is considered a common site for many benign,
primary malignant and metastatic focal lesions. Accurate
detection and characterization of these tumors is crucial beforetreatment to ensure correct staging, to prevent tumors from
being falsely rated as inoperable and patients with inoperable
tumors from being scheduled for surgical procedures (1).
Diffusion-weighted imaging (DWI) has been reported to be
useful for the early detection of small focal hepatic lesions.
Moreover, DWI offers the possibility to obtain criteria for
lesion characterization without the need for contrast agent
administration by quantifying diffusion effects via apparent
diffusion coefﬁcient (ADC) measurements, with better results
compared with those of conventional MR imaging (2).
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of patients with cancer in cirrhotic liver by improving lesion
detection over that achieved with standard breath-hold T2-
weighted imaging (3).
Dynamic three dimensional gradient-recalled-echo MR
imaging provides dynamic contrast-enhanced thin-section
images with fat saturation which is excellent for the proper
evaluation, accurate detection and characterization of various
focal hepatic lesions (4).
The aim of this study was to clarify the role of Diffusion
Weighted Magnetic Resonance Imaging (DW MRI) in the
detection of hepatic focal lesions and its ability to differentiate
benign from malignant hepatic focal lesions.
2. Patients and methods
This study included 40 patients over a period of 30 months
starting from August 2011 to February 2014. Those patients
were referred to Diagnostic Radiology Department at Tanta
University Hospital from the different medical and surgical
departments as well as oncology unit of Tanta University Hos-
pital. The 40 patients included in this study were 32 males and
8 females with age ranging from 30 to 80 years.
Patients with chronic renal impairment (high serum creati-
nine) or previous allergy to the contrast media were excluded
from the study. This study was approved by the ethics commit-
tee of Tanta Faculty of Medicine; an informed consent was
obtained from all patients after full explanation of the beneﬁts
and risks of the procedure.
All patients were subjected to careful history taking, general
and abdominal examination, laboratory examinations, and
liver MRI.
2.1. Liver MRI imaging protocol
All MR images were obtained on the available 1.5-T supercon-
ducting MRI scanner (Signa HD · 14.0, GE Healthcare)
installed in radiology department at Tanta university hospital.
As regards patient preparation, the patient was asked not
to eat or drink anything for 4–6 h before the scan. Jewellery
of any kind and any metallic objects were removed before
examination. Examination was performed in supine position,
with comfortable head pillows and the arms positioned com-
fortably next to the abdomen.
1. Unenhanced axial T1-weighted acquisitions. Parameters are
repetition time (TR) 150 to 200/msec, echo time (TE)
20 ms, optional fat suppression, matrix 256 · 192, ﬁeld of
view 320 mm, respiratory gating.
2. T1 (Axial spoiled GRE sequence applied in phase and out of
phase) (repetition time msec/echo time msec, 126/4.6 [in-
phase], 2.3 [out-of-phase]; ﬂip angle, 80; matrix,
179 · 256; section thickness, 8 mm; intersection gap,
2.5 mm; one signal acquired; ﬁeld of view, 320 mm).
3. Axial & Coronal T2-weighted fast spin-echo sequence with
spectral fat saturation (TR = 1800, TE = 85; fast spin-
echo factor, 16; matrix, 512 · 512; section thickness,
8 mm; intersection gap, 2.5 mm; ﬁeld of view, 320 mm),
fat suppression. Heavily T2-weighted pulse sequences
obtained with a minimum TE of 160 ms.4. Diffusion weighted sequences (Respiratory-triggered proto-
col using b value = 100 and 500 s/mm2). Before contrast
material injection, diffusion-weighted MR sequences were
performed with the single shot echo-planar imaging (EPI)
technique. These sequences combined diffusion gradient
pulses before the 2 and after the 180 pulse. Subsequent
measurement of mean apparent diffusion coefﬁcient
(ADC) value was done, for evaluation of suspected hepatic
masses in selected cases.
5. Dynamic contrast material–enhanced (Gd-DTPA) imaging
(Axial 3D spoiled GRE) was done. Axial dynamic 3D fat-
suppressed GRE sequence, FSPGR LAVA (liver acquisi-
tion with volume acceleration) was performed during all
phases after bolus injection of 0.2 mL/kg body weight of
Gd-DTPA ﬂushed with 20 ml of sterile 0.9% saline solution
in the antecubital vein at 20 s (arterial phase), 40 s (portal
phase), 60 s (venous phase), 120 s (equilibrium phase) and
again at 10 min and may be variable up to one hour after
injection (Delayed phase).
For lesion characterization all imaging results were reﬁned
against a predeﬁned standard of reference (SOR). The stan-
dard of reference was either histopathology (for nine cases)
or multi-modality and clinical follow-up (for the remaining
thirty-one cases). For each lesion type, the most appropriate
and ethically justiﬁable SOR was used. For 9 patients (HCC
5 cases, secondaries 3 cases and CCA one case) the accepted
SOR was biopsy and histopathological veriﬁcation within a
time frame of 3 months after MRI examination. Based on eth-
ical considerations, we did not expect to get SOR result for
every lesion detected in patients with multiple lesions. There
was no histopathological conﬁrmation for the benign lesions.
For patients presented with benign lesions the accepted
standard of reference was close follow up with contrast
enhanced MRI or triphasic CT study after few months.
2.2. Imaging evaluation
Images interpretation was done according to the difference in
the signal intensity, shape, site, size of the lesions and their
relations to the surrounding structures at the noncontrast
T1-weighted and T2-weighted pulse sequences. Next we
reviewed the dynamic images of our Gd-DTPA MRI study
for difference in the pattern of enhancement of the lesions with
proper localization. Finally we reviewed diffusion weighted
imaging (DWI) study in order to assess the added diagnostic
value in the detection and characterization of the hepatic focal
lesions. On DWI, restricted diffusion was considered if a lesion
showed increased signals to the normal liver parenchyma on
increasing b-value images, and when the ADC (apparent diffu-
sion coefﬁcient) map displayed a value lower or equal to liver
parenchyma. The readers visually evaluated the ADC map
qualitatively, comparing to that of normal surrounding liver
parenchyma. Quantitative analysis of ADC calculations based
on a threshold of 1.3 · 103 s/mm2. All lesions below that
threshold considered to be malignant lesions. Bright signal
on both diffusion images and ADC map is considered as T2
shine-through effect which was seen in hemangiomas and
cysts.
Evaluation of the fat contents of the lesions was done by
the dual in-phase and out-of-phase sequences. Histopatholo-
Table 1 Age and gender distribution of the studied 40
patients.
No. of patients Percentage (%)
Gender
Male 32 80
Female 8 20
Age
30 < 40 2 5
40 < 50 4 10
50 < 60 20 50
60 < 70 12 30
70 < 80 2 5
Table 2 Pathological classiﬁcation of the hepatic focal lesions
in the present study.
Lesion Number of patients Percentage (%)
Hepatocellular carcinoma 16 40
Metastasis 8 20
Multicentric HCC 6 15
Cirrhotic nodules 4 10
Focal fatty inﬁltration 2 5
Cholangiocarcinoma 2 5
Hemangioma 2 5
Total 40 100
Table 3 MR signal intensity characteristics of the hepatic focal les
The lesion T1 T2 Heavy T2 T1
HCC ﬂ › ﬂ Var
Metastasis ﬂ › ﬂ ﬂ
Cirrhotic nodules Iso/› Iso/ﬂ ﬂ ﬂ
CCA ﬂ Variable ﬂ ﬂ
Hemangioma ﬂ ›› ›› ﬂ
FFI › › – ›
Note: Arrows indicate increased (‘‘up’’ arrow) or decreased (‘‘down’’ arro
arrows indicate marked hyperintensity. Iso = isointense. Variable = var
intensity.
Table 4 Mean apparent diffusion coefﬁcients (ADCs) values of the
Lesion First sequence
(b-value 100)
HCC 1.168
Metastasis 0.686
CCA 0.925
Hemangioma 3.217
Benign lesions 2.942
Malignant lesions 1.059
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of secondaries and 1 case of CCA).
2.3. Statistical analysis
The role of Diffusion Weighted Magnetic Resonance Imaging
(DW MRI) in detection and characterization of hepatic focal
lesions was evaluated and compared with histopathology (for
nine cases) and multi-modality with clinical follow-up (for
the remaining thirty-one cases) which were considered the gold
standard of reference. Data entry was done by SPSS version 16
and analyzed by the same software.
A P value <0.05 was considered signiﬁcant.
3. Results
Forty patients were examined in this study, including 32 males
and 8 females with age range from 30 to 80 year (Table 1).
Among the 40 patients included in this study, males were
more than females representing 80% and the females 20%.
The age ranged 50 < 60 years was the most common affected
followed by age group 60 < 70 years and the less common age
affected was between 30 and 40 years.
Hepatocellular carcinoma (HCC) and metastasis are the
most common cause of hepatic focal lesions in this study rep-
resenting 75% of cases (30 cases) followed by cirrhotic nodules
that represented 10% of the cases (4 cases), hemangioma 5%
(2 cases), and cholangiocarcinoma 5% (2 cases) (Table 2).
HCC and secondaries show low SI in T1 & high SI in
T2WI, while CCA shows low SI in T1 and variable SI in
T2WI and all of them show restricted diffusion. Hemangiomaions in the studied 40 patients.
in phase T1 out phase Diﬀusion
Diﬀusion ADC map
iable intensity ﬂ › ﬂ
ﬂ › ﬂ
ﬂ Free Isointense
ﬂ › ﬂ
ﬂ › ›
ﬂ – –
w) signal intensity relative to the surrounding normal liver. Doubleup
iable intensity (hyperintense, hypointense or isointense). SI = signal
hepatic focal lesions in the studied 40 patients.
SD Second sequence
(b-value 500)
SD
0.068 1.21 0.05
0.553 0.75 0.048
0.11 0.825 0.11
0.155 2.827 0.102
0.611 2.879 0.651
0.281 0.991 0.267
328 A.A. Elbarbary et al.shows low SI in T1, very bright signal in T2WI, on heavy
weighted T2 still bright signal and on diffusion it shows high
signal in both diffusion and ADC map due to T2 shine
through. Focal fatty inﬁltration (FFI) shows high SI in both
T1 and T2WI with loss of signal on chemical shift sequence
(out of phase). Cirrhotic nodules show iso/high SI in T1, iso/
low SI in T2 and free diffusion, and ADC values less than
1.3 · 103 s/mm2 in all the malignant lesions, but ADC values
more than 1.3 · 103 s/mm2 in all benign lesions. Diagnosis of
malignant lesions based on typical MRI features, speciﬁc lab-
oratory tests and histopathology conﬁrmation for 9 cases (5A
C
T2 WI
Coronal T2 
E
DWI
Fig. 1 (A–F) Female patient aged 55 year presented with jaundice,
colon resection. MRI study revealed multiple hepatic focal lesions in bo
lobe and segment VIII & VI of the right hepatic lobe. All the lesions ex
& diffusion study (DWI) and hypointense on ADC map with mean AD
lobe exhibits only marginal restricted diffusion due to central necros
established as metastatic deposits based on the clinical history and thcases HCCs, 3 cases secondaries and one case Cholangiocarci-
noma) as shown in Table 3.
First sequence was done with b value = 100 s/mm2. Second
sequence was done with b value = 500 s/mm2. Mean ADC
value = 1.3 · 103 s/mm2 ± SD (Standard deviation). The
lowest ADCs were found in metastases, CCA and HCCs and
the highest values were found in hemangiomas. The difference
between the mean ADC values of benign and malignant
lesions was signiﬁcant. No signiﬁcant differences in ADC val-
ues among the different benign lesions or among the different
malignant lesions at both sequences (Table 4) Figs. 1–5.B
D
Coronal  T2 W
Coronal T1 WI
In Phase 
F
ADC 
epigastric pain and epigastric swelling with past history of cancer
th right and left hepatic lobes namely segment II of the left hepatic
hibit hypointense SI on T1WI, markedly hyperintense SI on T2WI
C value = 0.9 · 103 s/mm2. The largest lesion in the left hepatic
is with mean ADC value = 1.7 · 103 s/mm2. The diagnosis was
e MRI ﬁndings.
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lesions (multicentric HCC). All the patients with HCC show
cirrhotic liver and elevated a-fetoprotein. The size of the
lesions ranges from 1 to 7 cm with mean diameter 4 cm. All
the lesions show low SI in T1, high SI in T2WI with restricted
diffusion. No signiﬁcant differences in ADC values among dif-
ferent HCC lesions. Postcontrast all lesions show arterial
enhancement with rapid washout (Tables 5 and 6).A
C
E
T1 WI  
Diffusion 
(b value = 500) 
Arterial  phase
G
Delayed phas
Fig. 2 (A–G) Male patient aged 66 year with liver cirrhosis presented
left hepatic lobe nearly rounded mass with diameter = 6 cm, and the m
diffusion study and hypointense on ADC map with mean ADC value
enhancement at the arterial phase with rapid washout at the subseque
MRI ﬁndings of HCC together with histopathological conﬁrmation a4. Discussion
In the stage of malignant disease, metastatic involvement of
the liver has to be ruled out in almost all instances. Further-
more, the worldwide increasing number of primary hepatic
malignancies directs attention to an early and correct diagnosis
of these lesions, mainly hepatocellular carcinoma (HCC). The
importance of liver imaging lies in the accurate detection andB
D
F
T2 WI   
Portal  phase
Mean ADC value=  
1.12 x 10-3 mm2/sec
with clinically palpable epigastric swelling. MRI study revealed a
ass exhibits hypointense SI on T1WI, hyperintense SI on T2WI &
= 1.12 · 103 mm2/s. The mass showed immediate heterogeneous
nt porto-venous and delayed phases. The mass showed the typical
fter surgical excision (Left lobectomy).
A B
T1 
WI 
Coronal 
T2
DWI
  B value 
=500
T2 WI
C D
Fig. 3 (A–D) Male patient aged 55 years presented with obstructive jaundice. MRI ﬁndings: A tumor mass centralized upon the
common hepatic and left hepatic ducts and associated with bi-lobar biliary obstruction. The mass exhibits hypointense SI on both T1WI
and T2WI, heterogeneous high signal intensity on diffusion study and low SI in the ADC map with mean ADC value = 1.2 · 103 s/mm2.
The lesion showed typical imaging ﬁndings of cholangiocarcinoma.
330 A.A. Elbarbary et al.exact differentiation between the above-mentioned malignant
lesions and frequent benign lesions (5).
Although dynamic contrast enhanced examinations have
become a routine component of abdominal imaging, the high
cost/beneﬁt ratio and risk of contrast media side effects remain
an issue. MR Imaging has revealed high performance for focal
liver lesion detection and characterization during a single
examination procedure (6).
Diffusion weighted imaging (DWI) has recently emerged as
a tool for detecting cancers in the abdominal organ ﬁeld. The
use of DWI in the liver is relatively new (7).
The amount of diffusion is deﬁned using the diffusion coef-
ﬁcient. Diffusion coefﬁcient measurement in vivo is affected by
several factors in biological tissues. Capillary perfusion, tem-
perature, magnetic sensitivity of the tissue, and motion affect
the actual diffusion; therefore, the term ‘‘apparent diffusion
coefﬁcient’’ (ADC) is used rather than ‘‘diffusion coefﬁcient’’
(8).
Our study included 40 patients, 32 men and 8 women, with
age ranging from 30 to 80 years and mean age of 55 years,
which included the age incidence of malignant hepatic focal
lesions, which are more predominant after age of 50 which
was in line with other studies as follows:
A study was performed by Demir et al. (8) including thirty
patients with age ranging from 18 to 88 years and mean age
54.4 years. Parikh et al. (1) performed a study including ﬁfty-
three patients with age ranging from 25 to 83 and mean age
60.7 years. Kim et al. (3) carried out a study including forty-
nine patients with age ranging from 31 to 73 years and mean
age 55.9 years.
As regards patient’s sex, our study has male predominance,
32 men and 8 women, that went in line with other studies ashepatic lesions are more common in men. Cui et al. (9) per-
formed a study including 23 patients, 16 men and seven
women. Another study carried out by Koike et al. (10) includ-
ing seventy patients, 52 men and 18 women. Hosny (6) con-
ducted a study including thirty-eight patients, 27 men and 11
women.
Bachir and Dew (11) found that DW MR imaging signiﬁ-
cantly improved detection of small malignant lesions
(<2 cm) when compared with breath-hold T2-weighted imag-
ing in a study performed on 24 patients. Another study carried
out by Parikh et al. (9) showed signiﬁcantly improved detec-
tion rates of both malignant and benign focal lesions when
using DW imaging with a small b value compared with stan-
dard breath-hold T2-weighted imaging, particularly for small
malignant lesions measuring 1–3 cm.
Bruegel et al. (12) compared respiratory-triggered DW MR
imaging to T2-weighted sequence for the diagnosis of hepatic
metastases in 52 patients with 118 lesions at 1.5T. DW MR
imaging demonstrated higher accuracy compared with T2-
weighted fast SE techniques. These differences were even more
pronounced for small metastatic lesions (61 cm).
Zech et al.(13) compared black-blood DW MR imaging
(b= 50 s/mm2) with fat-suppressed T2-weighted imaging in
38 patients and observed signiﬁcantly better image quality,
fewer artifacts, and better sensitivity for lesion detection with
DW MR imaging.
Vandecaveye et al. (14) concluded that DWI is more sensi-
tive for the detection of HCC< 20 mm compared to conven-
tional contrast enhanced MRI, while DWI did not show
signiﬁcantly better results than conventional MRI in detecting
HCC> 20 mm.
A B
C D
E F
T1 WI
T2 WI
T1WI Coronal 
T2WI 
ADC    
DWI     
Fig. 4 (A–F) Male patient with history of cancer colon aged 65 years presented with chest wall mass and jaundice. MRI ﬁndings:
Multiple variable sized focal lesions scattered at both hepatic lobes. The lesions exhibit hypointense to isointense SI on T1WI,
Hyperintense signal on T2WI and diffusion study with mean ADC value = 0.38 · 103 s/mm2. The chest wall mass showed areas of high
SI in T1WI consistent with areas of hemorrhage. As regards the patient’s clinical history and MRI ﬁndings, the lesions were diagnosed as
metastatic deposits.
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noise ratio and background suppression of normal liver paren-
chyma and vascular or bile structures in DWI, which make
small lesions more visible, especially when they are in close
vicinity to vessels or bile ducts.
On T1-weighted MR images, HCC is most often hypoin-
tense relative to the liver, although hyperintense lesions or
areas of hyperintensity within hypointense lesions may be seen.
These hyperintense regions within the HCC reﬂect the presence
of fat, copper, protein, or blood secondary to intralesional
hemorrhage. On T2-weighted images, HCC is generally hyper-
intense, although well-differentiated lesions that are isointense
relative to the liver parenchyma may be seen. Most HCCs
show intense enhancement on arterial phase contrast-enhanced
images with rapid washout at the subsequent phases as
reported by Piana et al. (15).On arterial phase dynamic gadolinium-enhanced images,
most small HCCs show intense enhancement with rapid wash-
out at the portal phase. Nishie et al. (16) reported that at dif-
fusion-weighted imaging, HCCs have a variable appearance.
Well-differentiated tumors are often isointense, whereas mod-
erately to poorly differentiated tumors are more often hyperin-
tense with low ADC values compared to the well-differentiated
tumors.
In this study 22 patients with HCC were evaluated 20 males
and 2 females (mean diameter, 4 cm; range, 2–8 cm). Seven
cases were found in cirrhotic liver and 1 case was in a noncirrh-
otic liver. The diagnosis was straightforward and agreed with
the previous study as regards characteristic noncontrast MRI
signal, typical pattern of contrast enhancement as well as the
diffusion study criteria. The other 14 cases were found in cir-
rhotic liver with multicentric HCC in 6 cases.
A B
C
T1 WI 
T2 WI
Heavy T2 WI
D E
F
DWI  
(b value = 500) 
Arterial Phase 
Mean ADC value 
2.904 x 10-3mm2/sec 
G H
Porto-
venous 
phase  
Delayed  
Phase 
Fig. 5 (A–H) Female patient aged 51 year, presented with
hyperechoic left hepatic lobe focal lesion during US checkup. MRI
study revealed a small left hepatic lobe subcapsular focal lesion
exhibits hypointense SI on T1WI, hyperintense SI on T2 and
heavy T2 weighted images. The lesion appeared hyperintense on
diffusion study as well as at the ADC map with mean ADC
value = 2.9 · 103 s/mm2. The lesion showed incomplete ring of
peripheral nodular enhancement at the arterial phase after
contrast injection with gradual ﬁlling at the porto-venous phase
and complete ﬁlling with contrast at delayed images. The lesion
showed the typical MRI ﬁndings of the hemangioma.
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tion of liver metastases in patients with primary tumors is very
important because these patients may have benign lesions that
must be differentiated from metastases to avoid unnecessary
further diagnostic work-up or errors in patient staging.
Metastatic lesions usually demonstrate low signal intensity
on T1-weighted MR images and are iso to hyperintense on T2-
weighted images, with delayed enhancement on contrast-
enhanced images. Occasionally, they show early ring enhance-
ment. Islet cell tumors, breast cancer, cancer ovary, melanoma,
thyroid cancer, and carcinoid tumor are among the most com-
mon primary tumors that lead to hypervascular hepatic metas-
tases. Hypervascular metastases are best seen during the
arterial phase of enhancement and show washout on delayed
images. Most of these lesions have high signal intensity on
T2-weighted MR images (Soyer et al.) (18).
In our study, 29 metastatic lesions (mean diameter 4 cm)
were evaluated in 8 patients. The primary tumors were colorec-
tal carcinoma in 3 patients, urinary bladder cancer in 1 patient,
and unknown primary in 4 patients. The diagnosis of these
lesions was straightforward with the previous literatures as
regards the clinical history of primary malignancy, characteris-
tic noncontrast MRI features, pattern of contrast enhancement
as well as the diffusion study criteria.
Nasu et al. (19) reported that malignant hepatic tumors,
especially hepatic metastases, have a lower apparent diffusion
coefﬁcient than benign nodules. The hepatic metastases are
generally hyperintense on diffusion study with low ADC
values.
In our study, four patients were evaluated 2 males and 2
females, and regenerative nodules show low signal intensity
on T2 weighted images, variable signal intensity on T1
weighted images, and no enhancement on arterial phase
dynamic gadolinium-enhanced images.
These were in agreement with Hussain (20) who stated that
on MRI study cirrhotic nodules are seen as low-signal-inten-
sity areas on both T1 and T2 weighted MR images with no
enhancement after contrast material administration.
Hemangioma is the most common benign hepatic tumor.
On unenhanced MRI, the typical lesion is sharply deﬁned with
a geographic or rounded shape, hypointense on T1WI and
strongly hyperintense on T2WI images that may be as bright
as CSF. On contrast-enhanced images, hemangiomas demon-
strate early peripheral nodular enhancement with progressive
centripetal enhancement on subsequent images, this comes in
agreement with Bozgeyik et al. (21) who reported that early
phase images show peripheral enhancement which is typically
nodular and discontinuous with centripetal ﬁlling during the
portal venous and almost completely ﬁlled with contrast at
the delayed images.
At diffusion-weighted imaging, hemangiomas are hyperin-
tense, not because of restriction, but rather because of T2
shine-through. This is because hemangiomas are characterized
by an enlargement of the extra-cellular space compared to the
normal tissue. As a result, such lesions are expressed with free
diffusion and elevated ADC values. ADCs of hemangiomas
are greater than those of solid malignant lesions but are lower
than those of cysts, which is probably due to the vascular space
and thus blood ﬂow or perfusion within hemangiomas Goshi-
ma et al. (22).
The diagnosis of the 2 cases with hemangioma reported in
this study was straightforward with the previous literatures as
Table 5 Features of six randomly selected cases of HCCs.
Criteria for diﬀerentiation Case (1) Case (2) Case (3) Case (4) Case (5) Case (6)
Multi-focal Multi-focal
Cirrhotic liver + + + + + +
Noncirrhotic – – – – – –
a-Fetoprotein High High High High High High
Diameter 4 cm 3 cm 7 cm 2 cm 2–5 cm 3–6 cm
T1WI ﬂ ﬂ ﬂ ﬂ ﬂ ﬂ
T2WI › › › › › ›
Arterial phase › › › › › ›
Portal phase ﬂ ﬂ ﬂ ﬂ ﬂ ﬂ
Delayed ﬂ ﬂ ﬂ ﬂ ﬂ ﬂ
Diﬀusion ›restricted › › › › ›
Mean ADC 1.22 1.25 1.48 1.39 1.44 1.32
(b value = 100)
Mean ADC 1.09 1.09 1.33 1.30 1.31 1.28
(b value = 500)
Arrows indicate increased (‘‘up’’ arrow) or decreased (‘‘down’’ arrow) signal intensity relative to the surrounding normal liver. Iso = isointense.
(+) positive for cirrhosis. () negative for cirrhosis. 16 patients were evaluated 14 males and 2 females, 6 patients with multi-centric HCC.
Table 6 MR characteristic features of the metastatic lesions in the studied 40 patients.
Lesion Sequence
T1 T2 Heavy T2 Arterial phase Portal phase Delayed phase Diﬀusion
Colorectal carcinoma ﬂ › ﬂ ﬂ ﬂ ﬂ ›restricted
Urinary bladder cancer ﬂ › ﬂ ﬂ ﬂ ﬂ ›
Unknown primary ﬂ › ﬂ ﬂ ﬂ ﬂ ›
Note: ‘‘Up’’ arrow indicates homogenous enhancement. ‘‘Down’’ arrow indicates washout.
Role of Diffusion Weighted Magnetic Resonance Imaging 333regards characteristic noncontrast MRI signal, typical pattern
of contrast enhancement as well as the diffusion study criteria.
Cholangiocarcinoma is the second most common primary
malignant hepatic tumor in adults. The tumor can be classiﬁed
as peripheral intrahepatic, hilar intrahepatic, or extrahepatic
depending on its location. Intrahepatic cholangiocarcinoma
is usually hypointense on T1-weighted MR images and
hyperintense on T2-weighted images. On contrast-enhanced
images, it demonstrates initial peripheral enhancement with
concentric internal ﬁlling on delayed phase images (Manfredi
et al.) (23).
Peripheral cholangiocarcinomas in the post-Gd arterial and
portal venous phases the lesions show a strongly enhancing
rim of glandular tissue with a hypovascular center. Peripheral
washout with delayed and prolonged enhancement of the cen-
tral ﬁbrotic area is seen on later images. Central cholangiocar-
cinomas tend to present earlier with duct obstruction and are
usually smaller at the time of diagnosis. Their margins are typ-
ically very ill-deﬁned and there is little or no contrast with the
adjacent liver on unenhanced images. The lesions are hypoin-
tense on both T1 and T2 weighted images. The characteristic
feature is the presence of multiple dilated ducts, all converging
and tapering fairly abruptly at the site of the obstructing mass.
The tumors are hypovascular in arterial and portal phases with
gadolinium, but like peripheral tumors, central lesions show
delayed enhancement which persists Khan et al. (24).
In our study 2 male patients were evaluated one patient pre-
sented with hilar and one patient presented with peripheral
cholangiocarcinoma. The lesions follow the characteristicMRI criteria at the previous studies. Histopathological conﬁr-
mation was done for the 2 cases with cholangiocarcinoma.
The protocol of DWI in our study was carried out by using
respiratory-triggered protocol with b value (100 s/mm2) for
proper detection of the hepatic focal lesions and b value
(500 s/mm2) to overcome the effect of capillary perfusion and
water diffusion in extracellular extravascular space with subse-
quent reduction of signal from moving protons.
Aliya et al. (25) reported that the actual detection of liver
tumor is reported to be greater at low b values (50–150 s/
mm2). Parikh et al. (9) reported signiﬁcant improvement in
the detection of focal liver lesions with low b value diffusion-
weighted imaging compared with T2-weighted imaging. High
b values are considered to be more important for the character-
ization of focal liver lesions; however, the high signal intensity
of a lesion at high b values is most effectively interpreted in
conjunction with the lesion characteristics seen with other con-
ventional MR sequences.
The absolute ADC values of the different types of lesions
were not similar, which is probably due to differences in tech-
niques applied (b value, breath measurement methods, and
mathematical technique applied). This ﬁnding was also
recorded by Petra et al. (26), and they stated that in spite of
increasing number of studies dealing with quantitative mea-
surements of ADC in liver lesions, there are many discrepan-
cies in the reported ADC values where there is no cutoff
value for ADC values in normal parenchyma, benign and
malignant lesions and this is often associated with many tech-
nical parameters such as the use of respiratory-triggered versus
334 A.A. Elbarbary et al.breath-hold diffusion-weighted protocol and signiﬁcantly b
value as high b value results in low ADC value and vice versa.
This is agreeing with Bachir et al. (11) who revealed that ADCs
tend to be higher when using low b values.
The ﬁndings in our study were similar to the previous stud-
ies in many aspects as follows: the difference between the mean
ADC values of benign and malignant lesions was signiﬁcant
and no signiﬁcant differences in ADC values among the differ-
ent benign lesions or among the different malignant lesions
which supports similar previous ﬁndings where Onura et al.
(27) and Latif et al. (28) stated that the mean ADC values of
benign lesions were higher than malignant lesions and these
differences were signiﬁcant for all 3 diffusion gradients.
According to the present study it can be concluded that the
diffusion-weighted MR imaging alone performs equally well as
Gd-MRI in detection and differentiation of different hepatic
focal lesions. In cases where gadolinium injection is not
allowed, dynamic contrast-enhanced imaging can be replaced
by a protocol based on unenhanced T1 and T2 weighted imag-
ing combined with DWI. Adding DWI to Gd-MRI is more
accurate, indicating that it should be included in oncologic
liver MRI whenever possible.
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